There appeared to be no benefit for the subgroup with the highest NT-proBNP (> 5314 pg/ml) and SGLT-2 inhibitor use was low, so benefit in combination with vericiguat is less clear in this population. Patients on long-acting nitrates, PDE-5 inhibitors, IV inotropes, and LVADs were ...
Al-Barjas M, Nair D, Ayrton P, Morris R, Davar J (2004) How can the role of N terminal pro B natriuretic peptide (NT-proBNP) be optimised in heart failure screening? A prospective obsevational comparative study. Eur Heart J Fail 3(Suppl 1):51. doi:10.1016/ S1567-4215(04)90150-6...
which remains lower than those of other medical diagnostic disciplines (e.g., histopathology, with an error rate of nearly 5.0%) [2]. The pre-analytical phase, which is often plagued by a low degree of standardization, is the most vulnerable to errors, so that preventing and/or limiting t...